GOSSAMER BIO, INC. Adjustments to Additional Paid in Capital, Other
GOSSAMER BIO, INC. (GOSS) reported Adjustments to Additional Paid in Capital, Other of $16.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-17.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2023-03-17
- GOSSAMER BIO, INC. adjustments to additional paid in capital, other for the quarter ending 2020-09-30 was $16.00K.
- GOSSAMER BIO, INC. adjustments to additional paid in capital, other for the quarter ending 2019-06-30 was $39.00K.
- GOSSAMER BIO, INC. adjustments to additional paid in capital, other for fiscal 2020 was $16.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2020-12-31 | $16.00K 10-K · filed 2023-03-17 | |
| 2020-09-30 | $16.00K 10-Q · filed 2021-11-08 | |
| 2019-06-30 | $39.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |